Development
Semler Scientific, Inc.
SMLR
$30.25
-$1.18-3.75%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 9.15% | 16.15% | 25.47% | 29.89% | 19.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.15% | 16.15% | 25.47% | 29.89% | 19.52% |
| Cost of Revenue | 186.38% | -2.37% | 26.58% | 30.82% | -45.40% |
| Gross Profit | -7.46% | 17.79% | 25.39% | 29.83% | 34.51% |
| SG&A Expenses | 2.32% | -0.90% | 10.92% | 13.45% | 16.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.83% | -1.69% | 18.39% | 18.62% | 3.52% |
| Operating Income | -26.54% | 54.42% | 38.66% | 58.70% | 111.52% |
| Income Before Tax | -28.89% | 51.88% | 47.68% | 68.22% | 131.95% |
| Income Tax Expenses | -289.88% | 59.18% | 59.98% | 185.42% | 272.36% |
| Earnings from Continuing Operations | 31.25% | 50.04% | 44.31% | 47.89% | 113.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.25% | 50.04% | 44.31% | 47.89% | 113.40% |
| EBIT | -26.54% | 54.42% | 38.66% | 58.70% | 111.52% |
| EBITDA | -25.46% | 52.77% | 37.47% | 55.85% | 108.69% |
| EPS Basic | 29.07% | 49.17% | 45.45% | 49.59% | 115.52% |
| Normalized Basic EPS | -16.10% | 63.93% | 51.01% | 72.88% | 134.22% |
| EPS Diluted | 31.49% | 54.35% | 47.06% | 53.66% | 114.91% |
| Normalized Diluted EPS | -12.65% | 67.45% | 52.88% | 75.72% | 138.58% |
| Average Basic Shares Outstanding | 1.70% | 0.59% | -0.80% | -1.13% | -0.99% |
| Average Diluted Shares Outstanding | -2.32% | -1.53% | -2.02% | -2.72% | -2.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |